Evidence map›Paper›PMID 38339093›Full record

ArticleInternational journal of molecular sciences2024

Production of Bioactive Porcine Lactoferrin through a Novel Glucose-Inducible Expression System in

Chih-Ching Yen, Pei-Ying Wu, Huan Ou-Yang, Hsiao-Ling Chen, Kowit-Yu Chong, Ro-Lin Chang, Chuan-Mu Chen

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Special Issue "New Insights into Lactoferrin".International journal of molecular sciences · 2025
    Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Chih-Ching YenDepartment of Internal Medicine, China Medical University Hospital, College of Health Care, China Medical University, Taichung 404, Taiwan.ORCID 0000-0002-9355-7961
Pei-Ying WuDepartment of Life Sciences, Ph.D. Program in Translational Medicine, National Chung Hsing University, Taichung 402, Taiwan.
Huan Ou-YangDepartment of Life Sciences, Ph.D. Program in Translational Medicine, National Chung Hsing University, Taichung 402, Taiwan.ORCID 0000-0001-5207-6945
Hsiao-Ling ChenDepartment of Biomedical Science, Da-Yeh University, Changhua 515, Taiwan.
Kowit-Yu ChongDepartment of Medical Biotechnology and Laboratory Science, College of Medicine, Chang Gung University, Taoyuan 333, Taiwan.ORCID 0000-0003-0974-0673
Ro-Lin ChangDepartment of Life Sciences, Ph.D. Program in Translational Medicine, National Chung Hsing University, Taichung 402, Taiwan.ORCID 0000-0001-8363-1278
Chuan-Mu ChenDepartment of Life Sciences, Ph.D. Program in Translational Medicine, National Chung Hsing University, Taichung 402, Taiwan.ORCID 0000-0003-2461-9150
National Chung Hsing University · TWChang Gung University · TWDayeh University · TW

Funding

Ministry of Education, Taiwan MOE-112-S-0023-AMinistry of Science and Technology, Taiwan MOST-105-2321-B-005-010
6 · The paper itself

Abstract

Lactoferrin (LF) stands as one of the extensively investigated iron-binding glycoproteins within milk, exhibiting diverse biological functionalities. The global demand for LF has experienced consistent growth. Biotechnological strategies aimed at enhancing LF productivity through microbial expression systems offer substantial cost-effective advantages and exhibit fewer constraints compared to traditional animal bioreactor technologies. This study devised a novel recombinant plasmid, wherein the

Indexed as

Anti-Infective AgentsLactoferrinRecombinant ProteinsAnimalsCattleEscherichia coliFermentationGlucoseHumansPichiaSaccharomycetalesStaphylococcus aureusSwineAnti-Infective AgentsGlucoseLactoferrinRecombinant ProteinsanticancerantimicrobialfermentationG1 promoteriron-bindinglactoferrinPichia pastoristangential-flow ultrafiltration

Identifiers

PMID38339093
PMCPMC10855427
OpenAlexW4391472543

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.